Trending...
- Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
- Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
- UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global bone tumor ablation devices market is estimated to be valued at US$ 56.2 million in 2020 and is expected to exhibit a CAGR of 10.2% during the forecast period (2020-2027).
Key Trends and Analysis of the Global Bone Tumor Ablation Devices Market:
Successful and multiple use of the microwave ablation technique for the treatment of various diseases is expected to increase the sales of bone tumor ablation devices worldwide, thereby strengthening the position of the companies in the global market. For instance, according to the doctors at National Taiwan University are successfully using microwave energy to minimally invasively treat tumors in the lung with higher local success rate of 84% compared to historical 67-78% reported, as of December 2019.
Major companies in the Europe region are involved in various growth strategies such collaboration, acquisition for research and development of new technology, in order to enhance their market presence. For instance, Medtronic plc acquired OsteoCool device technology from Baylis Medical in 2015.
Various key players in the market are entering the market through inorganic growth strategies such as mergers and acquisitions. For instance, in August 2020, Olympus Corporation announced signing of a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. Under the agreement, Olympus will acquire Arc Medical Design and obtain full rights of its medical products. Post-acquisition, Olympus Corporation is planning to design, manufacture, and distribute the products worldwide.
More on Washingtoner
Furthermore, rising adoption of ablation devices by the surgeons for treatment in different therapeutic categories is expected to drive growth of the market in the Middle East. For instance, in 2019, IceCure Medical, an Israel-based company, received Israeli AMAR authorization (an Israeli Ministry of Health's medical device regulation unit) to use its freezing technology in treatment of benign and malignant tumors of bones, liver, lymphatic tissue, lymph nodes, and endocrine glands.
Request Sample Copy of this Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4319
Key Market Takeaways:
The global bone tumor ablation devices market is expected to exhibit a CAGR of 10.2% during the forecast period (2020-2027), owing to the rising prevalence of bone cancer, or rare bone disorders worldwide. For instance, according to the National Organization for Rare Disorders, Ewing sarcoma affects males more often than females. It may affect individuals of any age, but most often occurs in individuals between 10 and 20 years of age. The annual incidence of Ewing sarcoma is 2.93 children per 1,000,000 in the U.S. Around 200-250 children and adolescents in the U.S. are diagnosed with a tumor in the Ewing family of tumors, each year.
Competitive Landscape:
Key players in the North America bone tumor ablation devices market are focused on development of various bone tumor ablation devices, which is expected to drive growth of the market during the forecast period. For instance, in December 2015, DFINE, Inc., announced the commercial launch of its Long SpineSTAR Ablation Instrument. Long SpineSTAR is the latest innovation by the Silicon Valley medical device manufacturer and is part of the company's flagship STAR Tumor Ablation System.
More on Washingtoner
Key players operating in the global bone tumor ablation devices market include Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.
Buy-Now this Research Report for detailed market insights: https://www.coherentmarketinsights.com/insight/buy-now/4319
Bone Tumor Ablation Devices Market Segmentation:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.
Key Trends and Analysis of the Global Bone Tumor Ablation Devices Market:
Successful and multiple use of the microwave ablation technique for the treatment of various diseases is expected to increase the sales of bone tumor ablation devices worldwide, thereby strengthening the position of the companies in the global market. For instance, according to the doctors at National Taiwan University are successfully using microwave energy to minimally invasively treat tumors in the lung with higher local success rate of 84% compared to historical 67-78% reported, as of December 2019.
Major companies in the Europe region are involved in various growth strategies such collaboration, acquisition for research and development of new technology, in order to enhance their market presence. For instance, Medtronic plc acquired OsteoCool device technology from Baylis Medical in 2015.
Various key players in the market are entering the market through inorganic growth strategies such as mergers and acquisitions. For instance, in August 2020, Olympus Corporation announced signing of a definitive agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. Under the agreement, Olympus will acquire Arc Medical Design and obtain full rights of its medical products. Post-acquisition, Olympus Corporation is planning to design, manufacture, and distribute the products worldwide.
More on Washingtoner
- Inframark Expands Its Specialized Automation and Intelligence Capabilities, Adds Dmytryka Jacobs Engineers
- Sustainable Santa Returns to Old Sacramento
- Upcoming Launch of Retail Crypto Cloud Mining Platform with Daily Rewards in a Transparent Revenue-Share Model: iMD Companies, Inc. Stock Symbol: ICBU
- BumblebeeSmart Introduces Rounded Busy Board Set for Preschoolers
- CRH Healthcare Opens 100th Urgent Care Clinic with Second Peachtree Immediate Care Location in Covington
Furthermore, rising adoption of ablation devices by the surgeons for treatment in different therapeutic categories is expected to drive growth of the market in the Middle East. For instance, in 2019, IceCure Medical, an Israel-based company, received Israeli AMAR authorization (an Israeli Ministry of Health's medical device regulation unit) to use its freezing technology in treatment of benign and malignant tumors of bones, liver, lymphatic tissue, lymph nodes, and endocrine glands.
Request Sample Copy of this Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4319
Key Market Takeaways:
The global bone tumor ablation devices market is expected to exhibit a CAGR of 10.2% during the forecast period (2020-2027), owing to the rising prevalence of bone cancer, or rare bone disorders worldwide. For instance, according to the National Organization for Rare Disorders, Ewing sarcoma affects males more often than females. It may affect individuals of any age, but most often occurs in individuals between 10 and 20 years of age. The annual incidence of Ewing sarcoma is 2.93 children per 1,000,000 in the U.S. Around 200-250 children and adolescents in the U.S. are diagnosed with a tumor in the Ewing family of tumors, each year.
Competitive Landscape:
Key players in the North America bone tumor ablation devices market are focused on development of various bone tumor ablation devices, which is expected to drive growth of the market during the forecast period. For instance, in December 2015, DFINE, Inc., announced the commercial launch of its Long SpineSTAR Ablation Instrument. Long SpineSTAR is the latest innovation by the Silicon Valley medical device manufacturer and is part of the company's flagship STAR Tumor Ablation System.
More on Washingtoner
- COHN Named Colorado State-Approved Vendor for Advertising & Marketing Services
- The Kryder Law Group, LLC Report Reveals Commercial Air Travel Is Safer Than You Think
- RTC Communications Preliminarily Awarded $3.1 Million Federal BEAD Grant to Expand Fiber Broadband in Southern Indiana
- She's Been Ready for Weeks, He Starts in the Final 72 Hours – The Great Christmas Shopping Divide
- Following a Global Sell-Out, The World's No.1 Superstar™ Unveils a Fashion Line Rebrand
Key players operating in the global bone tumor ablation devices market include Medtronic Plc., Merit Medical Systems Inc., MedWaves Inc., AngioDynamics Inc., Olympus Corporation, Varian Medical Systems, Inc., Mermaid Medical A/S, RF Medical Co., Ltd., and Misomix Inc.
Buy-Now this Research Report for detailed market insights: https://www.coherentmarketinsights.com/insight/buy-now/4319
Bone Tumor Ablation Devices Market Segmentation:
- By Technology:
- Radiofrequency Ablation
- Microwave Ablation
- Cryoablation
- Others
- By Indication:
- Osteosarcoma
- Chondrosarcoma
- Ewing's Sarcoma
- Metastatic Bone Cancer Bone Cancer Bone Cancer
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- By Region:
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- North America
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. Our client base includes players from across various business verticals in over 57 countries worldwide.
Filed Under: Business
0 Comments
Latest on Washingtoner
- GenesisEdge Society Unveils ΣClipse AI Multi-Agent System Led by Richard Schmidt
- Uk Financial Ltd Provides Investors Of Maya Preferred & Mayacat Instructions For Upcoming First Ever Listing Of Both Erc-3643 "SEC-Ready" Tokens
- Tacoma Creates 2024-2025 Annual Report Highlights Expanded Access to Arts and Culture Across Tacoma
- Kaufman Development and Daniel Kaufman Ventures Announce Strategic Expansion Into Data Centers and AI Infrastructure Across the United States
- Tacoma: City Council Presented with Community Safety Action Strategy Built on Community Input
- City Council Presented With 'Tacoma 2035'
- Bent Danholm Lists Modern Lakefront Estate in Winter Garden's Twinwaters Community
- Operational Agility in High Demand: FOCUS Expands to Serve a Changing Insurance Market
- Bahamas Import Assistant Launches Same-Day Pet Permit Service Under BAHFSA's 2024 Expansion
- Liftoff Enterprises Launches Liftoff Spotlight,™ A Nationally Broadcast Platform Turning Conversations Into Revenue
- From November 24th to 27th, Fuqing Invites You to Join Us at BIG 5 to Jointly Build a New Future for Middle Eastern Architecture
- Dispelling Holiday Suicide Myth: CDC Data Shows Suicide Rates Lowest in December; International Survivors of Suicide Day Emphasizes Need for Action
- Stratum Nutrition's OVOLUX™ Named 2025 "Collagen Ingredient of the Year" by Beauty Innovation Awards
- Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025
- Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
- North 5th Street – Between North Tacoma Avenue and North Division Avenue – to Close in Phases for Maintenance Starting December 1
- Bent Danholm Releases New Video Breaking Down the Rising Debate Over 50-Year Mortgages
- New Smile Now Introduces RAYFace 3D Scanner to Advance Digital Surgery
- Ali Alijanian, DDS Featured in The Profitable Dentist Magazine
- "Meet the Eatmons" Offer Financial Advice ahead of the Holidays